Roivant Sciences Ltd. (ROIV)
NASDAQ·Healthcare·Biotechnology
$30.28
+1.88%
Mkt Cap $20.49B
Analyst Ratings
Buy
11
Hold
0
Sell
0
Price Target (24 analysts)
$31.50
Range $30.00 – $34.00
Implied Upside
+4.0%
Consensus $31.50 vs current $30.28
NASDAQ·Healthcare·Biotechnology
$30.28
+1.88%
Mkt Cap $20.49B
Buy
11
Hold
0
Sell
0
Price Target (24 analysts)
$31.50
Range $30.00 – $34.00
+4.0%
Consensus $31.50 vs current $30.28